Vertex Pharmaceuticals Gets FDA OK for Sickle Cell Disease Treatment in Young Children
By Elias SchisgallThe Food and Drug Administration approved the use of Vertex Pharmaceuticals's sickle cell disease treatment, Casgevy, for patients as young as two years old.The agency said Wednesday that it issued a supplemental approval for the drug, known generically as exagamglogene autotemcel…